Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Xarelto in Japanese patients with acute symptomatic pulmonary embolism
NCT01516814Phase 3Completed
- Sponsor
- Bayer
- Start
- Feb 2012
- Primary completion
- Oct 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of rivaroxaban in pulmonary embolism (PE), deep vein thrombosis (DVT), sponsored by Bayer. Started Feb 2012; status: completed.
02
Drugs
rivaroxaban
03
Conditions
pulmonary embolism (PE)deep vein thrombosis (DVT)
Beyond the preview
Go deeper on NCT01516814.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01516814.